CASTAGNA, LUCA
CASTAGNA, LUCA
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Outcome of Allogeneic Transplantation for Mature T-cell Lymphomas: Impact of Donor Source and Disease Characteristics
2022 M. Hamadani, M. Ngoya, A. Sureda, Q. Bashir, C.A. Litovich, H. Finel, Y. Chen, A. Boumendil, J. Zain, L. Castagna, A.F. Cashen, D. Blaise, M. Shadman, R. Pastano, F. Khimani, M. Arat, S. Dietrich, N. Schmitz, B. Glass, M.A. Kharfan-Dabaja, P. Corradini, C.S. Sauter, S. Montoto, M. Kwon, A.F. Herrera, P. Dreger
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand
2022 J.J.P. van Beek, S. Puccio, C. Di Vito, F. De Paoli, E. Zaghi, M. Calvi, A. Scarpa, C. Peano, G. Basso, J. Cibella, C. De Philippis, B. Sarina, I. Timofeeva, R. Capizzuto, D. Mannina, R. Mineri, J. Mariotti, R. Crocchiolo, A. Santoro, L. Castagna, S. Bramanti, D. Mavilio, E. Lugli
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
2022 J. Mariotti, A.M. Raiola, A. Evangelista, S. Harbi, F. Patriarca, M.A. Carella, M. Martino, A. Risitano, A. Busca, L. Giaccone, L. Brunello, E. Merla, L. Savino, B. Loteta, G. Console, R. Fanin, A. Sperotto, L. Marano, S. Marotta, C. Frieri, S. Sica, P. Chiusolo, C. Chabannon, S. Furst, A. Santoro, A. Bacigalupo, B. Bruno, D. Blaise, D. Mavilio, S. Bramanti, R. Devillier, E. Angelucci, L. Castagna
Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies
2021 L. Castagna, V. Valli, I. Timofeeva, R. Capizzuto, S. Bramanti, J. Mariotti, C. De Philippis, B. Sarina, D. Mannina, L. Giordano, F. De Paoli, J.J.P. van Beek, E. Zaghi, M. Calvi, C.D. Vito, D. Mavilio, R. Crocchiolo, E. Lugli
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 R.W. Merryman, L. Castagna, L. Giordano, V.T. Ho, P. Corradini, A. Guidetti, B. Casadei, D.A. Bond, S. Jaglowski, M.A. Spinner, S. Arai, R. Lowsky, G.L. Shah, M.-. Perales, J.M.S. De Colella, D. Blaise, A.F. Herrera, G. Shouse, C. Spilleboudt, S.M. Ansell, Y. Nieto, T. Badar, M. Hamadani, T.A. Feldman, L. Dahncke, A.K. Singh, J.P. McGuirk, T. Nishihori, J. Chavez, A.V. Serritella, J. Kline, M. Mohty, R. Dulery, A. Stamatoulas, R. Houot, G. Manson, M.-. Moles-Moreau, C. Orvain, K. Bouabdallah, D. Modi, R. Ramchandren, L. Lekakis, A. Beitinjaneh, M.J. Frigault, Y.-. Chen, R.C. Lynch, S.D. Smith, U. Rao, M. Byrne, J.T. Romancik, J.B. Cohen, S. Nathan, T. Phillips, R.M. Joyce, M. Rahimian, A. Bashey, H.J. Ballard, J. Svoboda, V. Torri, M. Sollini, C. De Philippis, M. Magagnoli, A. Santoro, P. Armand, P.L. Zinzani, C. Carlo-Stella
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT
2021 E. Zaghi, M. Calvi, S. Puccio, G. Spata, S. Terzoli, C. Peano, A. Roberto, F. De Paoli, J.J.P. van Beek, J. Mariotti, C. De Philippis, B. Sarina, R. Mineri, S. Bramanti, A. Santoro, V.T.K. Le-Trilling, M. Trilling, E. Marcenaro, L. Castagna, C. Di Vito, E. Lugli, D. Mavilio
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas
2021 L. Castagna, A. Dodero, F. Patriarca, F. Onida, A. Olivieri, D. Russo, L. Giordano, I. Majolino, S. Bramanti, J. Mariotti, B. Sarina, C. De Philippis, L. Farina, C. Carlo-Stella, P. Corradini, A. Santoro
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
2021 G. Lia, C. Di Vito, S. Bruno, M. Tapparo, L. Brunello, A. Santoro, J. Mariotti, S. Bramanti, E. Zaghi, M. Calvi, L. Comba, M. Fascì, L. Giaccone, G. Camussi, E.M. Boyle, L. Castagna, A. Evangelista, D. Mavilio, B. Bruno
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation
2021 J.J.P. Van Beek, S. Puccio, A. Roberto, F. De Paoli, G. Graziano, E. Salviato, G. Alvisi, V. Zanon, A. Scarpa, E. Zaghi, M. Calvi, C. Di Vito, R. Mineri, B. Sarina, C. De Philippis, A. Santoro, J. Mariotti, S. Bramanti, F. Ferrari, L. Castagna, D. Mavilio, E. Lugli
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
2020 J. Mariotti, A.M. Raiola, A. Evangelista, A.M. Carella, M. Martino, F. Patriarca, A. Risitano, S. Bramanti, A. Busca, L. Giaccone, L. Brunello, E. Merla, L. Savino, B. Loteta, G. Console, R. Fanin, A. Sperotto, L. Marano, S. Marotta, C. Frieri, S. Sica, P. Chiusolo, S. Harbi, S. Furst, A. Santoro, A. Bacigalupo, D. Blaise, E. Angelucci, D. Mavilio, L. Castagna, B. Bruno
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
2020 L. Castagna, A. Busca, S. Bramanti, M. Raiola Anna, M. Malagola, F. Ciceri, W. Arcese, D. Vallisa, F. Patriarca, G. Specchia, R. Raimondi, R. Devillier, S. Furst, L. Giordano, B. Sarina, J. Mariotti, A. Olivieri, R. Bouabdallah, C. Carlo-Stella, A. Rambaldi, A. Santoro, P. Corradini, A. Bacigalupo, F. Bonifazi, D. Blaise
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma : a retrospective study of the Lymphoma Working Party—EBMT
2020 L. Bento, A. Boumendil, H. Finel, I. Khvedelidze, D. Blaise, N. Fegueux, L. Castagna, E. Forcade, P. Chevallier, N. Mordini, P. Brice, E. Deconinck, M. Gramatzki, P. Corradini, M. Hunault, M. Musso, A. Tsoulkani, D. Caballero, S. Nati, S. Montoto, A. Sureda
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC
2019 P. Dreger, A. Sureda, K.W. Ahn, M. Eapen, C. Litovich, H. Finel, A. Boumendil, A. Gopal, A.F. Herrera, C. Schmid, J.L. Diez-Martin, E. Fuchs, J. Bolaños-Meade, M. Gooptu, M.M. Al Malki, L. Castagna, S.O. Ciurea, A. Dominietto, D. Blaise, F. Ciceri, J. Tischer, P. Corradini, S. Montoto, S. Robinson, Z. Gülbas, M. Hamadani
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
2019 A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, D. Blaise, K.S. Peggs, B. Afanasyev, J.L. Diez-Martin, P. Corradini, D. Michonneau, S. Robinson, G. Gutiérrez García, F. Bonifazi, I. Yakoub-Agha, Z. Gülbas, A. Bloor, J. Delage, A. Esquirol, R. Malladi, C. Scheid, J. El-Cheikh, H. Ghesquières, S. Montoto, P. Dreger, A. Sureda
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide
2019 J. Mariotti, D. Taurino, F. Marino, S. Bramanti, B. Sarina, L. Morabito, C. De Philippis, C. Di Vito, D. Mavilio, C. Carlo-Stella, M. Della Porta, A. Santoro, L. Castagna
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
2018 A. Mussetti, C. de Philippis, C. Carniti, M. Bastos-Oreiro, J. Gayoso, N. Cieri, M. Pennisi, F. Ciceri, R. Greco, J. Peccatori, F. Patriarca, J. Mariotti, L. Castagna, P. Corradini
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party
2018 A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, K.S. Peggs, D. Blaise, B. Afanasyev, J.L. Diez-Martin, J. Sierra, A. Bloor, C. Martinez, S. Robinson, R. Malladi, J. El-Cheikh, P. Corradini, S. Montoto, P. Dreger, A. Sureda
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
2017 F. Patriarca, L. Giaccone, F. Onida, L. Castagna, B. Sarina, V. Montefusco, A. Mussetti, N. Mordini, E. Maino, R. Greco, J. Peccatori, M. Festuccia, F. Zaja, S. Volpetti, A. Risitano, R. Bassan, P. Corradini, F. Ciceri, R. Fanin, M. Baccarani, A. Rambaldi, F. Bonifazi, B. Bruno
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
2017 G. van Gorkom, M. van Gelder, D. Eikema, H. Blok, M.T. van Lint, Y. Koc, F. Ciceri, D. Beelen, P. Chevallier, D. Selleslag, D. Blaise, R. Foà, P. Corradini, L. Castagna, C. Moreno, C. Solano, L.P. Muller, J. Tischer, I. Hilgendorf, M. Hallek, J. Bittenbring, M. Theobald, J. Schetelig, N. Kroger
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis
2017 L. Castagna, A. Mussetti, R. Devillier, A. Dominietto, M. Marcatti, G. Milone, F. Maura, C. de Philippis, B. Bruno, S. Furst, D. Blaise, P. Corradini, V. Montefusco